文献速递神经肿瘤脊柱脊髓外科

原发性脊髓星形细胞瘤:低级别与高级别病变的双中心临床经验

Primary Spinal Cord Astrocytomas: Two-Center Clinical Experience of Low- and High-Grade Lesions.
PubMed 文献 · World Neurosurg · 2022-09-05

本研究为1997至2020年双中心回顾性分析,纳入7例WHO I级、6例II级、7例III级和4例IV级原发性脊髓星形细胞瘤患者,排除有脱落转移或无至少一次随访者。中位随访15个月,8例影像学进展,6例死亡,10例末次随访症状加重。结论认为级别越高结局越差,术后病程困难,临床医生应警惕血栓栓塞并发症,需进一步研究。

要点

  • 年龄较大者级别较高(I级中位20岁 vs IV级36.5岁)。
  • I、II、III、IV级中位无进展生存期分别为116、36、8、8.5个月。
  • I、II、III、IV级中位总生存期分别为142、69、19、12个月。

核心结论

  • 级别越高结局越差,并导致术后病程困难。
  • 临床医生应警惕血栓栓塞并发症。
  • 需要进一步研究以理解这些罕见肿瘤。

研究设计与样本

  • 1997至2020年双中心回顾性分析原发性脊髓星形细胞瘤患者。
  • 排除有脱落转移或无至少一次随访的患者。
  • 纳入7例WHO I级、6例II级、7例III级和4例IV级星形细胞瘤患者。
  • 中位随访15个月。

主要发现

  • 年龄较大者级别较高(I级中位20岁 vs IV级36.5岁)。
  • 13例患者出院后接受康复治疗。
  • 8例患者出现影像学进展。
  • 辅助治疗在更高级别中使用更多(III级13例中5例 vs IIIIV级11例全部)。
  • 6例患者死亡(III级1例死亡 vs IIIIV级5例死亡)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Primary spinal cord astrocytomas are rare, fatal, and poorly studied. METHODS: This study included a 2-center, retrospective analysis of primary spinal cord astrocytoma patients from 1997 to 2020. Patients with drop metastases or without at least one follow-up were excluded. RESULTS: Seven World Health Organization grade I, 6 grade II, 7 grade III, and 4 grade IV astrocytoma patients were included. Older patients had higher grades (median 20 years in grade I vs. 36.5 in grade IV). The median follow-up was 15 months. Thirteen patients were discharged to rehabilitation. Eight patients demonstrated radiographic progression. Adjuvant therapy was utilized more in higher grades (5 of 13 grades III vs. all 11 grades IIIIV). Six patients died (1 death in grades III vs. 5 in grades IIIIV). Ten patients had worsened symptoms at the last follow-up. The median progression-free survival in grade I, II, III, and IV tumors was 116, 36, 8, and 8.5 months, respectively. The median overall survival in grade I, II, III, and IV tumors was 142, 69, 19, and 12 months, respectively. Thrombotic complications occurred in 2 patients, one with isocitrate dehydrogenasewild type glioblastoma. CONCLUSIONS: Outcomes worsen with higher grades and lead to difficult postoperative periods. Clinicians should be vigilant for thromboembolic complications. Further research is needed to understand these rare tumors.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Snyder MH, Yu-Der Wang A, Ampie L, et al. Primary Spinal Cord Astrocytomas: Two-Center Clinical Experience of Low- and High-Grade Lesions. World Neurosurg. 2022. PMID: 36064118. doi:10.1016/j.wneu.2022.08.130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。